NCT01403077View on ClinicalTrials.gov

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

October 31, 2015

Conditions
Superficial Femoral Artery LesionsAtherosclerosis of Femoral Artery
Interventions
DEVICE

480 Biomedical Bioresorbable Scaffold System

480 Biomedical Bioresorbable Scaffold System

Trial Locations (6)

Unknown

The Alfred, Melbourne

Universitäts Klinikum Graz, Graz

Universitaet Freiburg-Bad Krozingen, Freiburg im Breisgau

Park Hospital - Heart Center Leipzig, Leipzig

RoMed Klinikum Rosenheim, Rosenheim

Auckland City Hospital, Auckland

Sponsors

Lead Sponsor

480 Biomedical
All Listed Sponsors
lead

480 Biomedical

INDUSTRY